This company has shut down. MicThera is no longer operating — its last tracked round was a Seed in 2024.
Explore the Startup GraveyardMicThera is a biotech company that develops microbial derived therapeutics to provide effective treatments for prostate cancer patients.
MicThera has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
MicThera's investors include Indaco Venture Partners.
MicThera is headquartered in Zürich, Switzerland.
MicThera is a biotech company that develops microbial derived therapeutics to provide effective treatments for prostate cancer patients.
MicThera is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MicThera — Funding & Investors." VCBacked, May 30, 2024, https://www.vcbacked.co/company/micthera. Accessed November 14, 2026.
VCBacked. (2024). MicThera — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/micthera
{{cite web |title=MicThera — Funding & Investors |url=https://www.vcbacked.co/company/micthera |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MicThera? Request a listing update